Celebrating innovators on the streets of MIND
A ceremony to re-name the first three streets of MIND – Milano Innovation District took place today marking an important milestone in the district’s project to celebrate and give visibility to lesser known or forgotten innovators. The famous Decumano of the universal Exposition will officially become “Viale Decumano” and the area surrounding the Tree of Life will be known as “Piazzale Expo 2015.
Meanwhile the Cardo, headquarters of Human Technopole, will be named after Rita Levi-Montalcini, Nobel prize for Medicine and stander-bearer for Italian research around the world.
President of the Italian Senate Maria Elisabetta Alberti Casellati, Milan Mayor Giuseppe Sala and President of Lombardy Region Attilio Fontana attended the ceremony to unveil the new plaques.
The project is a joint effort between MIND partners: Arexpo, Human Technopole, Lendlease, Università degli Studi di Milano, Istituto Ortopedico Galeazzi and Fondazione Triulza. The aim of the initiative is to underline the identity and values of MIND as an ecosystem for innovation. Over the past few months MIND partners have drafted and submitted to the Comune di Milano a proposal to rename the streets as well as the squares, the buildings and the parks of the district. The outcome was a joint and integrated project celebrating and remembering scientists, researchers and relevant personalities in science and technology which have contributed to the progress of humanity.
One of the objectives of the initiative is to give tribute to the extraordinary contribution of female scientists and innovators, too often underestimated or even forgotten. Today in Italy only 5% of places are named after women, compared to a much higher proportion of men. MIND partners hope to have at least 50% of streets named after women as toponymy represents a fundamental tool to value and promote among the general public the important contributions made by women to the development of our societies.
The initiative is in line with the #RememberMyName campaign launched in March 2020 by Human Technopole to share the stories and revolutionary discovers of lesser-known scientists.
“Arexpo is aiming to transform an area as important as the one that hosted Expo into a unique innovation district for Italy and among the most important in the world. The project is now becoming a reality and the naming of the first MIND streets is proof of this. Research and innovation are the decisive challenges in a fast-changing world, but it is also important we celebrate the legacy of science and of the 2015 universal Exposition” explains Igor De Biasio CEO of Arexpo.
Human Technopole Foundation President Marco Simoni underlines: “Alongside Rita Levi-Montalcini who has been universally recognised, there are equally great figures such as the British biochemist Rosalind Franklin, whose work was fundamental for the discovery of the structure of DNA, who have been kept in the dark. This has often been the case for female scientists. Fostering trust in science is also achieved by knowing and celebrating those people whose discoveries have improved our daily lives. With the #RememberMyName campaign we celebrated “forgotten” scientists: women and men who have played a fundamental role in scientific progress but whose name is often unknown. An initiative we promote once again today with this ceremony and which will also be a prize for primary schools as part of the “A City in MIND” competition to name spaces of HT after these important figures”.
Andrea Ruckstuhl, Head of Italy and Continental Europe for Lendlease commented: “The personalities that we have chosen to celebrate teach us that innovation, science and technology are a shared heritage at the service of mankind to improve our quality of life. These extraordinary men and women are a source of inspiration, encouraging us to promote ideas and projects that will make MIND a unique excellence in the world: a resilient, inclusive and sustainable city of the future”.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.